Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of oral paclitaxel solution RMX3001/DHP107 versus Taxol injection as second-line treatment for advanced gastric cancer
CTR20190050Phase 3Completed
- Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel oral solution in gastric cancer (GC), sponsored by Daehwa Pharmaceutical Co., Ltd.. Started Apr 2019; status: completed.
02
Drugs
paclitaxel oral solution
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on CTR20190050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190050.